Concentrum Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $732K | Sell |
6,605
-762
| -10% | -$84.5K | 0.23% | 40 |
|
|
2025
Q1 | $825K | Sell |
7,367
-4,729
| -39% | -$530K | 0.31% | 39 |
|
|
2024
Q4 | $1.12M | Sell |
12,096
-3,585
| -23% | -$331K | 0.39% | 33 |
|
|
2024
Q3 | $1.31M | Buy |
15,681
+10,298
| +191% | +$863K | 0.51% | 26 |
|
|
2024
Q2 | $369K | Sell |
5,383
-3,001
| -36% | -$206K | 0.16% | 50 |
|
|
2024
Q1 | $614K | Buy |
8,384
+1,618
| +24% | +$119K | 0.28% | 37 |
|
|
2023
Q4 | $548K | Buy |
6,766
+413
| +7% | +$33.5K | 0.29% | 37 |
|
|
2023
Q3 | $476K | Buy |
+6,353
| New | +$476K | 0.29% | 39 |
|